172 related articles for article (PubMed ID: 37309708)
1. Chirality-Dependent Reprogramming of Macrophages by Chiral Nanozymes.
Zhang Y; Cui T; Yang J; Huang Y; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(34):e202307076. PubMed ID: 37309708
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer.
Chen X; Jia Z; Wen Y; Huang Y; Yuan X; Chen Y; Liu Y; Liu J
Acta Biomater; 2022 Oct; 151():537-548. PubMed ID: 35981687
[TBL] [Abstract][Full Text] [Related]
3. Chiral Ruthenium Nanozymes with Self-Cascade Reaction Driven the NO Generation Induced Macrophage M1 Polarization Realizing the Lung Cancer "Cocktail Therapy".
Chen X; Yang Y; Ye G; Liu S; Liu J
Small; 2023 Jul; 19(28):e2207823. PubMed ID: 37029560
[TBL] [Abstract][Full Text] [Related]
4. Defect-Rich Metastable MoS
Cui M; Qian L; Lu K; Liu J; Chu B; Wu X; Dong F; Song B; He Y
Small; 2024 Jun; ():e2402101. PubMed ID: 38888117
[TBL] [Abstract][Full Text] [Related]
5. Nanozyme-Based Enhanced Cancer Immunotherapy.
Phan NM; Nguyen TL; Kim J
Tissue Eng Regen Med; 2022 Apr; 19(2):237-252. PubMed ID: 35099759
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
[TBL] [Abstract][Full Text] [Related]
7. ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy.
Mo W; Liu S; Zhao X; Wei F; Li Y; Sheng X; Cao W; Ding M; Zhang W; Chen X; Meng L; Yao S; Diao W; Wei H; Guo H
Adv Healthc Mater; 2023 Aug; 12(21):e2300191. PubMed ID: 37031357
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy.
Wu X; Cheng Y; Zheng R; Xu K; Yan J; Song P; Wang Y; Rauf A; Pan Y; Zhang H
ACS Appl Mater Interfaces; 2021 May; 13(17):19825-19835. PubMed ID: 33881837
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation-Enhanced Nanozyme-Based Tumor Catalytic Therapy.
Xu B; Cui Y; Wang W; Li S; Lyu C; Wang S; Bao W; Wang H; Qin M; Liu Z; Wei W; Liu H
Adv Mater; 2020 Aug; 32(33):e2003563. PubMed ID: 32627937
[TBL] [Abstract][Full Text] [Related]
11. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
12. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
[TBL] [Abstract][Full Text] [Related]
13. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
14. Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy.
Zeng W; Yu M; Chen T; Liu Y; Yi Y; Huang C; Tang J; Li H; Ou M; Wang T; Wu M; Mei L
Adv Sci (Weinh); 2022 Aug; 9(23):e2201703. PubMed ID: 35678111
[TBL] [Abstract][Full Text] [Related]
15. Noble metal nanoparticle-induced oxidative stress modulates tumor associated macrophages (TAMs) from an M2 to M1 phenotype: An in vitro approach.
Pal R; Chakraborty B; Nath A; Singh LM; Ali M; Rahman DS; Ghosh SK; Basu A; Bhattacharya S; Baral R; Sengupta M
Int Immunopharmacol; 2016 Sep; 38():332-41. PubMed ID: 27344639
[TBL] [Abstract][Full Text] [Related]
16. A Biomimetic Polymer Magnetic Nanocarrier Polarizing Tumor-Associated Macrophages for Potentiating Immunotherapy.
Liu L; Wang Y; Guo X; Zhao J; Zhou S
Small; 2020 Sep; 16(38):e2003543. PubMed ID: 32812355
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
19. Adoptive transfer of Fe
Zhang Y; Liu S; Li D; He C; Wang D; Wei M; Zheng S; Li J
Colloids Surf B Biointerfaces; 2023 Sep; 229():113452. PubMed ID: 37474429
[TBL] [Abstract][Full Text] [Related]
20. Nanozymes with Peroxidase-like Activity for Ferroptosis-Driven Biocatalytic Nanotherapeutics of Glioblastoma Cancer: 2D and 3D Spheroids Models.
Carvalho SM; Mansur AAP; da Silveira IB; Pires TFS; Victória HFV; Krambrock K; Leite MF; Mansur HS
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
